CORRECTION article

Front. Oncol., 14 March 2024

Sec. Breast Cancer

Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1393626

Corrigendum: CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation

  • 1. Cancer Research Laboratory, Department of Zoology, University of Calcutta, Kolkata, India

  • 2. Cell Biology Laboratory, Department of Microbiology, University of Calcutta, Kolkata, India

  • 3. Department of Zoology, Charuchandra College, Kolkata, India

  • 4. Centre for Research in Nanoscience and Nanotechnology, University of Calcutta, Kolkata, India

In the published article, there was an error in Figure 6 as published. In Figure 6E, multiple β-tubulin blots were incorporated erroneously in between the immunoblot panel. The relative protein expressions in this panel were estimated to their respective β-tubulin expressions at the end of the panel only. The corrected Figure 6 and its caption appear below.

Figure 6

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

Clec12A, artemisinin, TLR4, autophagy, apoptosis, cancer stem cells

Citation

Chatterjee R, Shukla A, Chakrabarti K and Chatterji U (2024) Corrigendum: CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation. Front. Oncol. 14:1393626. doi: 10.3389/fonc.2024.1393626

Received

29 February 2024

Accepted

04 March 2024

Published

14 March 2024

Volume

14 - 2024

Edited and reviewed by

Nitin Telang, Palindrome Liaisons Consultants, United States

Updates

Copyright

*Correspondence: Urmi Chatterji,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics